advertisement

---

Journal of Ocular Pharmacology and Therapeutics 2

Showing records 1 to 2 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

6175 Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension
Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 251-259

---

6215 Effect of SR121463, a selective non-peptide vasopressin V sub(2) receptor antagonist, in a rabbit model of ocular hypertension
Lacheretz F; Barbier A; Serradeil-Le Gal C; Elena PP; Maffrand JP; Le Fur G
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 203-216

---